Ivanova · Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2024 · systematic review and meta-analysis · n=26 studies (5978 participants)

The Association of Vitamin D with Uterine Fibroids in Premenopausal Patients: A Systematic Review and Meta-Analysis.

Cited 9 times in the scientific literature.

Level 1 - systematic review of randomized trials

Systematic review and meta-analysis of randomized controlled trials and observational studies

PubMed 39128544 · doi:10.1016/j.jogc.2024.102632 · record verified 2026-08-29

What was done

Authors conducted a systematic review and random-effects meta-analysis of studies published up to February 2023 examining the link between vitamin D and uterine fibroids diagnosed via ultrasonography in premenopausal women. Databases searched included Medline, Embase, CINAHL, Web of Science, ClinicalTrials.gov, and grey literature. Methodological quality was assessed using the Newcastle-Ottawa Scale and Risk of Bias-2 tools, and evidence quality was evaluated using GRADE. The analysis pooled 3 randomized controlled trials (n = 328) and 23 observational studies (n = 5650).

What was found

Oral vitamin D supplementation in patients with insufficiency was associated with a significant difference in fibroid size change over 2 to 6 months compared to controls (standardized mean difference -5.7%, 95% CI -10.63 to -0.76, P = 0.02, I2 = 99%). Supplementation regimens ranged from 50,000 IU biweekly for 10 weeks to 50,000 IU weekly for 8 to 12 weeks. Patients with fibroids had lower serum vitamin D concentrations (mean difference -5.50 ng/mL, 95% CI -6.99 to -4.01, P < 0.001, I2 = 87%) and higher odds of vitamin D deficiency (OR 3.71, 95% CI 1.90 to 7.24, P < 0.001, I2 = 80%).

Why it matters

This review synthesizes clinical and observational evidence showing that vitamin D deficiency is associated with uterine fibroids and indicates that oral supplementation may help inhibit fibroid growth in premenopausal patients.

Limits

The interventional findings rely on only 3 small RCTs totaling 328 participants with variable dosing regimens and durations. There was extreme statistical heterogeneity across all meta-analyses (I2 from 80% to 99%), and most included data were observational.

Cited by